Behavior of Monoclonal Antibodies: Relation between the Second Virial Coefficient (B ) at Low Concentrations and Aggregation Propensity and Viscosity at High Concentrations
Pharmaceutical Research, ISSN: 0724-8741, Vol: 29, Issue: 2, Page: 397-410
2012
- 137Citations
- 174Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations137
- Citation Indexes137
- 137
- CrossRef128
- Captures174
- Readers174
- 174
Article Description
Purpose: To investigate relationship between second virial coefficient B and viscosity and aggregation propensity of highly concentrated monoclonal antibody (MAbs) solutions. Methods: Intermolecular interactions of 3 MAbs solutions with varying pH were characterized according to B2 estimated by analytical ultracentrifugation sedimentation equilibrium with initial loading concentrations <10 mg/mL. Viscosity measurements and stability assessments of MAb solutions at concentrations higher than 100 mg/mL were conducted. Results: B of all MAb solutions depended on solution pH and have qualitative correlation with viscosity and aggregation propensity. The more negative the B values, the more viscous the solution, acquiring increased propensity to aggregate. Solutions with B values of ~2×10 mL·mol/g acquire similar viscosity and aggregation propensity regardless of amino acid sequences; for solutions with negative B values, viscosity and aggregation propensity differed depending on sequences. Results suggest attractive intermolecular interactions represented by negative B values are influenced by surface properties of individual MAbs. Conclusions B can be used, within certain limitations, as an effective indicator of viscosity and aggregation propensity of highly concentrated MAb solutions. © Springer Science+Business Media, LLC 2011.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84860877016&origin=inward; http://dx.doi.org/10.1007/s11095-011-0563-x; http://www.ncbi.nlm.nih.gov/pubmed/21853361; http://link.springer.com/10.1007/s11095-011-0563-x; http://www.springerlink.com/index/10.1007/s11095-011-0563-x; http://www.springerlink.com/index/pdf/10.1007/s11095-011-0563-x; https://dx.doi.org/10.1007/s11095-011-0563-x; https://link.springer.com/article/10.1007/s11095-011-0563-x
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know